Cervical Cancer Treatments: Current Obstacles and Future Prospects
*Corresponding Author:Received Date: May 01, 2024 / Published Date: May 27, 2024
Copyright: © 2024 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Abstract Cervical cancer is the fourth most frequent malignancy in women worldwide, accounting for over 300,000 fatalities. Cervical cancer is caused by persistent infection with high-risk subtypes of the human papillomavirus. The viral oncoproteins E5, E6, and E7 work along with host factors to produce and maintain the malignant phenotype. Cervical cancer is mostly avoidable, and early detection leads to much higher survival rates. In high-income countries with robust vaccination and screening programs, the disease is infrequent. Women in low- and middle-income countries with inadequate resources commonly have advanced and untreatable disease, making it a fatal disease. Treatment options include surgery, chemotherapy, and radiotherapy, either individually or in combination
